Potassium iodide (KI) is one of the most discussed and most misunderstood radiation emergency preparations. It protects against one specific hazard — radioactive iodine uptake by the thyroid gland — and does nothing for any other radiation exposure or any other organ. Understanding exactly what it does and doesn’t do is essential for making a rational stockpiling decision and knowing when to actually use it.
How KI Protects the Thyroid
The thyroid gland actively concentrates iodine from the bloodstream to produce thyroid hormones. In a nuclear event, radioactive iodine-131 (a major fission product) is released into the environment. It behaves chemically identically to stable (non-radioactive) iodine — the thyroid cannot distinguish between them and concentrates both.
Taking stable KI before or immediately after radioactive iodine exposure saturates the thyroid with non-radioactive iodine, leaving no capacity for the thyroid to absorb I-131. The radioactive iodine passes through the body without being concentrated in the thyroid, dramatically reducing thyroid dose and the subsequent risk of thyroid cancer.
What KI does NOT do:
- Does not protect any other organ
- Does not reduce whole-body radiation dose from external gamma radiation
- Does not protect against any other radioactive isotopes (cesium-137, strontium-90, plutonium)
- Is not a “radiation antidote” or general protection against nuclear fallout
Who Benefits Most from KI
Thyroid cancer risk from radioactive iodine is highest in children under 18 — the younger, the higher the risk. Adults over 40 have significantly lower risk of developing thyroid cancer from I-131 exposure because the thyroid gland absorbs less iodine with age. FDA guidance:
| Group | KI priority | Rationale |
|---|---|---|
| Newborns to 1 month | Highest | Very high thyroid absorption rate; highest cancer risk |
| Children 1 month–18 years | High | High thyroid absorption; lifetime cancer risk high |
| Adults 18–40 | Moderate | Some thyroid absorption; meaningful cancer risk |
| Pregnant women (any age) | High | Fetal thyroid begins functioning at 12 weeks; fetus has same risk as infant |
| Adults over 40 | Low unless high exposure expected | Reduced thyroid absorption; lower cancer risk; higher side effect risk |
FDA Dosing by Age
| Age group | KI dose | Tablet fraction (130 mg tablet) |
|---|---|---|
| Adults ≥18 years | 130 mg | 1 tablet (or 2 × 65 mg tablets) |
| Children 3–18 years | 65 mg | ½ × 130 mg tablet |
| Children 1 month–3 years | 32.5 mg | ¼ × 130 mg tablet crushed in juice/food |
| Newborns to 1 month | 16.25 mg | ⅛ × 130 mg tablet (consult physician if possible) |
KI is taken once per day for as long as emergency management directs. It is most effective when taken before exposure or within 3–4 hours after. After 8 hours, effectiveness is significantly reduced. After 24 hours, KI provides no measurable protection for I-131 already absorbed.
Brands, Availability, and Storage
- Iosat (Anbex): 130 mg tablets, 14 tablets per package. The most widely available FDA-approved KI brand. Available at many pharmacies without prescription. Cost: $10–15 per package.
- ThyroShield (Fleming & Company): Liquid potassium iodide solution, 65 mg/mL. Easier to dose for infants and young children. More expensive per dose than tablets.
- Shelf life: FDA requires KI manufacturers to maintain a shelf life of at least 7 years from the date of manufacture. When stored in the original sealed packaging at room temperature, KI typically maintains potency beyond this period.
- State distribution programs: States within 10 miles of nuclear power plants are required to maintain KI distribution plans. Approximately 20 states distribute free KI to residents near nuclear facilities — check with your state emergency management agency.
When to Take KI: The Decision
KI should be taken only when directed by emergency management or when there is confirmed radioactive iodine release affecting your location. Do not take KI preemptively for unconfirmed events — the side effects (thyroid suppression, allergic reactions, iodine toxicity at high doses) are real risks, particularly for people with thyroid conditions, iodine allergy, or dermatitis herpetiformis.
The nuclear and radiological emergency preparedness guide — including the full fallout shelter protocol, the 7-10 decay rule, and decontamination procedures — is in nuclear and radiological emergency: shelter, potassium iodide, and fallout survival.
